Hajar Daulah

Dr. Hajar Dauleh is a Qatar-based pediatric endocrinologist at Sidra Medicine, Doha, with a clinical and research focus on pediatric obesity, dyslipidemia, and endocrine disorders in children. She is particularly involved in the development of specialized obesity services for pediatric patients and has established an Obesity and Dyslipidemia Clinic at Sidra Medicine.

She is also a faculty member of the Qatar Pediatric Endocrine and Diabetes Conference (QPEDC) 2026, where she is scheduled to address novel treatments for monogenic obesity and when to refer a child with obesity to an endocrine clinic.

Current Institution

Sidra Medicine, Doha, Qatar

Specialty: Pediatric Endocrinology

Clinical focus: Pediatric obesity, dyslipidemia and pediatric endocrine disorders.

Education and Medical Training

According to her official Hamad Medical Corporation biography:

• 2015: Earned her medical degree from Dubai Medical College (DMCG).
• Completed her internship and pediatric residency through Hamad Medical Corporation/Sidra Medicine.
• Obtained Arab Board Certification in Pediatrics.
• 2023: Completed her Pediatric Endocrinology fellowship at Sidra Medicine.

Her training therefore progressed from general medical education into pediatrics and subsequently into the subspecialty of pediatric endocrinology.

Clinical Career

Following her pediatric training, Dr. Dauleh developed a subspecialty practice in pediatric endocrinology, with particular attention to childhood obesity and lipid disorders.

One of her notable professional contributions has been the establishment of the Obesity and Dyslipidemia Clinic at Sidra Medicine. She also runs a specialized obesity clinic for pediatric patients in addition to participating in general pediatric endocrine clinics.

Her clinical interests correspond closely with the growing need for specialized management of childhood obesity and metabolic complications, including dyslipidemia.

Research Interests

Her officially documented research interests include:

• Pediatric obesity
• Dyslipidemia
• Pediatric endocrinology
• Metabolic complications of childhood obesity
• Obesity treatment
• Monogenic obesity
• Pediatric endocrine disorders

Her QPEDC 2026 faculty topics further demonstrate her interest in precision approaches to obesity, particularly emerging treatments for monogenic obesity and appropriate referral of children with obesity to specialist endocrine services.

Professional Society Involvement

Dr. Dauleh is a member of several international pediatric endocrine and diabetes organizations, including:

• European Society for Paediatric Endocrinology (ESPE)
• Arab Society for Pediatric Endocrinology and Diabetes (ASPED)
• Young Enteroendocrine Society (YES)

She has also been involved with the communication committee of ASPED and contributed to the establishment of the Young Arab Pediatric Endocrinology Society (YAPES).